Citigroup Forecasts Strong Price Appreciation for Procter & Gamble (NYSE:PG) Stock

Key Points

• Citigroup raised Procter & Gamble’s price target to $187 from $180 and maintained a “buy” rating, implying approximately 15.8% upside from the reported share price. The analyst consensus remains “Moderate Buy,” with an average target of $167.35.
• P&G reported quarterly earnings of $2.00 per share on $23.28 billion in revenue, surpassing estimates and marking 4% year-over-year revenue growth. Management also raised its fiscal 2027 sales-growth outlook while maintaining its EPS guidance range.
• Rising commodity, energy and transportation costs are expected to reduce annual profit by roughly $1.4 billion, creating margin pressure and uncertainty about whether volume growth can offset inflationary expenses.

Procter & Gamble (NYSE:PG - Get Free Report) had its price target raised by equities research analysts at Citigroup from $180.00 to $187.00 in a report issued on Friday, Benzinga reports. The firm presently has a "buy" rating on the stock. Citigroup's target price would suggest a potential upside of 15.82% from the company's current price.

Other analysts have also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Procter & Gamble in a research note on Friday. BNP Paribas Exane boosted their price target on Procter & Gamble from $177.00 to $189.00 and gave the company an "outperform" rating in a report on Friday. Barclays upped their price target on Procter & Gamble from $146.00 to $152.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 21st. Jefferies Financial Group raised their price objective on Procter & Gamble from $177.00 to $179.00 and gave the stock a "buy" rating in a research note on Friday, June 26th. Finally, The Goldman Sachs Group reaffirmed a "neutral" rating and issued a $161.00 price objective on shares of Procter & Gamble in a report on Thursday. Fourteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $167.35.

Procter & Gamble Stock Down 2.5%

NYSE PG traded down $4.13 during trading hours on Friday, reaching $161.46. 5,417,172 shares of the company traded hands, compared to its average volume of 9,741,831. Procter & Gamble has a 12 month low of $137.62 and a 12 month high of $167.25. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $375.03 billion, a PE ratio of 24.40, a PEG ratio of 3.90 and a beta of 0.39. The company has a 50 day moving average of $148.08 and a two-hundred day moving average of $146.99.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, topping the consensus estimate of $1.89 by $0.11. The company had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The company's revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.99 EPS. As a group, equities analysts expect that Procter & Gamble will post 6.98 earnings per share for the current year.

Insider Buying and Selling at Procter & Gamble

In related news, CAO Matthew Janzaruk sold 359 shares of the business's stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $145.24, for a total transaction of $52,141.16. Following the completion of the transaction, the chief accounting officer owned 1,271 shares in the company, valued at $184,600.04. The trade was a 22.02% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Marc Pritchard sold 4,030 shares of the company's stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total value of $579,473.70. Following the transaction, the insider owned 187,001 shares of the company's stock, valued at approximately $26,888,873.79. The trade was a 2.11% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 15,135 shares of company stock worth $2,189,970. 0.23% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in shares of Procter & Gamble in the second quarter valued at approximately $27,862,105,000. State Street Corp raised its holdings in shares of Procter & Gamble by 1.0% during the second quarter. State Street Corp now owns 102,216,308 shares of the company's stock valued at $14,988,999,000 after buying an additional 965,461 shares during the last quarter. Bank of America Corp DE acquired a new position in shares of Procter & Gamble during the second quarter worth approximately $3,850,628,000. Bank of New York Mellon Corp bought a new position in Procter & Gamble in the 2nd quarter worth approximately $2,281,505,000. Finally, Dimensional Fund Advisors LP grew its holdings in Procter & Gamble by 2.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company's stock worth $1,704,182,000 after buying an additional 300,280 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G reported fiscal Q1 adjusted earnings of $2.00 per share and revenue of $23.28 billion, exceeding consensus estimates of $1.89 and $22.80 billion, respectively. Revenue increased 4% year over year. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Organic sales growth reaccelerated 4%, with volume contributing 2.4 percentage points. Stronger demand in laundry, home-care and other categories, along with favorable product mix and productivity savings, helped drive the beat.
• Positive Sentiment: Management raised its fiscal 2027 all-in sales-growth outlook, partly reflecting the Thorne acquisition, while maintaining a roughly $86.0 billion-$87.7 billion revenue range and $6.89-$7.11 EPS guidance. P&G raises FY2027 sales outlook
• Positive Sentiment: JPMorgan raised its price target from $162 to $180 and upgraded its stance to overweight, indicating confidence that resilient volumes and improving operating leverage can support further appreciation.
• Neutral Sentiment: TD Cowen increased its target from $150 to $166 but retained a hold rating, signaling limited upside at the current valuation. P&G trades at approximately 24 times earnings, making sustained growth important for additional gains.
• Negative Sentiment: Higher commodity, energy, transportation and fuel costs are expected to pressure fiscal-year profit by roughly $1.4 billion. Analysts also noted that margins remain under strain despite pricing, productivity measures and favorable mix. P&G flags bigger profit hit from commodity costs
• Negative Sentiment: The company’s revenue guidance range remains below the roughly $88.8 billion analyst consensus, and investors still face uncertainty over whether volume growth can offset inflationary costs through the rest of fiscal 2027.

Procter & Gamble Company Profile

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.